# Anticoagulation With Rivaroxaban in Cardioversion -The ARC Study

> **NCT01747746** · PHASE4 · COMPLETED · sponsor: **Cook County Health** · enrollment: 33 (actual)

## Conditions studied

- Atrial Fibrillation
- Stroke
- Thrombo-embolism
- Bleeding

## Interventions

- **DRUG:** Rivaroxaban
- **DRUG:** Warfarin and Enoxaparin

## Key facts

- **NCT ID:** NCT01747746
- **Lead sponsor:** Cook County Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2015-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01747746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01747746, "Anticoagulation With Rivaroxaban in Cardioversion -The ARC Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01747746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*